EXPANDED TABLE OF CONTENTS
VOLUME 10, NUMBER 4 APRIL 2007
|
| TREATMENT HIGHLIGHTS |
| GENETIC AND ENVIRONMENTAL INFLUENCES ON THE RISK OF DEVELOPING SCHIZOPHRENIA |
| Adoptees with a high genetic risk for schizophrenia spectrum disorders are found to be sensitive to environmental influences.
|
| PSYCHOTHERAPEUTIC ADJUNCTS TO PHARMACOTHERAPY FOR BIPOLAR DISORDER |
| In patients with bipolar depression, intensive psychosocial treatment as an adjunct to pharmacotherapy is found to improve outcome.
|
| PSYCHIATRIC DISORDERS AMONG BARIATRIC SURGERY CANDIDATES |
| Among patients applying for bariatric surgery, both past and current psychiatric disorders are found to be common and are associated with both greater severity of obesity and a poorer functional health status.
|
| QUICKSTATS |
| Use of Marijuana and Blunts Among Adolescents |
| PSYCHOTROPIC DRUG COMPARISON STUDY |
| ANTIPSYCHOTIC MEDICATION AND PSYCHOSOCIAL FUNCTIONING |
| Second-generation antipsychotic medications are found to be associated with only modest improvement in psychosocial functioning in patients with schizophrenia. |
| FDA NEWS AND REVIEW |
| Product Safety Information: The labeling of drugs used to induce and/or maintain sleep (ie, sedative-hypnotics) has been revised to strengthen language concerning the risk of severe adverse reactions and complex sleep-related behaviors, which may include sleep-driving. |
| Product Safety Information: Pergolide is being withdrawn from the market due to the potential for heart valve damage. The product has been sold as Pergolide (generic) and as Permax (trade name). |
| ASSESSMENT |
| Robson Self Concept Questionnaire |
| RESOURCES |
| Each issue presents descriptions of clinical resources (eg, professional materials, patient handouts) and information on how to receive those materials. |
